Abstract
Genetic causes of Alzheimer's disease (AD) include mutations in the amyloid precursor protein (APP), presenilin 1 (PS1), and presenilin 2 (P52) genes1. The mutant APPK670N,M67M transgenic line, Tg2576, shows markedly elevated amyloid β-protein (AP) levels at an early age and, by 9–12 months, develops extracellular AD-type Ap deposits in the cortex and hippocampus2. Mutant PS1 transgenic mice do not show abnormal pathology, but do display subtly elevated levels of the highly amyloidogenic 42- or 43-amino acid peptide Aβ342(43) (ref. 3). Here we demonstrate that the doubly transgenic progeny from a cross between line Tg2576 and a mutant PS1M46L transgenic line develop large numbers of fibrillar Aβ deposits in cerebral cortex and hippocampus far earlier than their singly transgenic Tg2576 litter-mates. In the period preceding overt Aβ deposition, the doubly transgenic mice show a selective 41% increase in Aβ42(43) in their brains. Thus, the development of AD-like pathology is substantially enhanced when a P51 mutation, which causes a modest increase in Aβ42(43), is introduced into Tg2576-derived mice. Remarkably, both doubly and singly transgenic mice showed reduced spontaneous alternation performance in a “Y” maze before substantial Aβ deposition was apparent. This suggests that some aspects of the behavioral phenotype in these mice may be related to an event that precedes plaque formation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hardy, J., Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20, 154–159 (1997).
Hsiao, K., et al. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice Science 274, 99–102 (1996).
Duff, K., et al. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710–713 (1996).
Gravina, S., et al. Amyloid beta protein (Aβ) in Alzheimer's disease brain: Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43). J. Biol. Chem. 270, 7013–7016 (1995).
Scheuner, D., et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864–870 (1996).
Borchelt, D.R., et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1–42/1–40 ratio in vitro and in vivo. Neuron 17, 1005–1013 (1996).
Citron, M., et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nature Med. 3, 67–72 (1997).
Good, M. & Honey, R. Dissociable effects of selective lesions to hippocampal subsystems on exploratory behavior, contextual learning and spatial learning. Behav. Neurosci. 111, 487–493 (1997).
Logue, S., Paylor, R. & Wehner, J. Hippocampal lesions cause learning deficiencies in the Morris water maze and conditioned fear task. Behav. Neurosci. 111,104–113 (1997).
Laghmouch, A., Bertholet, J. & Crusio, W. Hippocampal morphology and open field behavior in Mus musculus domesticus and Mus spretus inbred mice. Behav. Genet. 27, 67–73 (1997).
Moran, P.M., Higgins, L.S., Cordell, B. & Moser, P.C. Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein. Proc. Natl. Acad. Sci. USA 92, 5341–5345 (1995).
Hsiao, K., et al. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 5, 1203–1218 (1995).
Wild-Bode, C., et al. Intracellular generation and accumulation of amyloid beta-peptide terminating at amino acid 42. J. Biol. Chem. 272,16085–16088 (1997).
Hartmann, T., et al. Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides. Nature Med. 3, 1016–1020 (1997).
LaFerla, F.M., Troncoso, J.C., Strickland, D.K., Kawas, C.H. & Jay, G. Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Aβ stabilization. J. Clin. Invest. 100, 310–320 (1997).
Masliah, E., et al. Comparison of neurodegenerative pathology in transgenic mice overexpressing the V717F β-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 16, 5795–5811.
Lalonde, R. & Thifault, S. Absence of an association between motor coordination and spatial orientation in lurcher mutant mice. Behav. Genet. 24, 497 (1994).
Maurice, T., et al. Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res. 706, 181 (1996).
Gordon, M., et al. Exaggerated astrocyte reactivity after nigrostriatal deafferenta-tion in the aged rat. J. Comp. Neurol. 388, 106–119 (1997).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Holcomb, L., Gordon, M., McGowan, E. et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4, 97–100 (1998). https://doi.org/10.1038/nm0198-097
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0198-097
This article is cited by
-
Regulation of cerebral blood flow boosts precise brain targeting of vinpocetine-derived ionizable-lipidoid nanoparticles
Nature Communications (2024)
-
Neurophysiological alterations in mice and humans carrying mutations in APP and PSEN1 genes
Alzheimer's Research & Therapy (2023)
-
Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer’s Mouse Model of Amyloid Deposition
Neuroscience Bulletin (2023)
-
Critical thinking of Alzheimer’s transgenic mouse model: current research and future perspective
Science China Life Sciences (2023)
-
Aβ promotes CD38 expression in senescent microglia in Alzheimer’s disease
Biological Research (2022)